Mendham, NJ, United States of America

Melvin Tecotzky


Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 276(Granted Patents)


Company Filing History:


Years Active: 1976-1999

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Melvin Tecotzky: Innovator in Photodynamic Therapy

Introduction

Melvin Tecotzky is a notable inventor based in Mendham, NJ (US), recognized for his contributions to the field of photodynamic therapy. With a total of 13 patents to his name, Tecotzky has made significant advancements in medical technology, particularly in devices that enhance treatment efficacy.

Latest Patents

Among his latest innovations is a photodynamic therapy apparatus and methods. This device is designed to apply light in a specific pattern that corresponds to the configuration of the lesion being treated. It can be customized based on images of the patient taken prior to treatment. Additionally, the device may incorporate sensors that detect characteristics of the tissue overlying each region, allowing it to emit light selectively based on the tissue's properties. Another significant patent is for a photostimulable phosphor, which falls within a specific empirical formula, enhancing radiation image recording and reproduction.

Career Highlights

Throughout his career, Melvin Tecotzky has worked with prominent companies such as Agfa Gevaert NV and U.S. Radium Corporation. His work in these organizations has contributed to the development of innovative technologies that have impacted the medical field.

Collaborations

Tecotzky has collaborated with notable individuals in his field, including Paul Leblans and Albert D Adriaensens. These partnerships have fostered an environment of innovation and creativity, leading to advancements in medical devices.

Conclusion

Melvin Tecotzky's contributions to photodynamic therapy and his extensive patent portfolio highlight his role as a significant innovator in medical technology. His work continues to influence the field, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…